Evaluation of the implementation of screening programs for early detection of breast and cervical cancer in the Gomel region
https://doi.org/10.51523/2708-6011.2023-20-2-12
Abstract
Objective. Conduct a comprehensive assessment of the indicators of screening programs for early detection of breast and cervical cancer in the Gomel region.
Materials and methods. A total of 7,611 first-time detected cases of breast cancer and 1,370 cases of cervical cancer in the Gomel region were analyzed for the period 2012-2022 (according to Belarusian Cancer Registry). The results of examination of 105130 participants of the screening program for early detection of breast cancer and 70258 participants of the screening program for early detection of cervical cancer were analyzed.
Results. During the period 2017-2022, due to screening, 12% of cases of breast cancer were detected from the total number of newly diagnosed malignant breast pathologies. From 2018 to 2022, the proportion of newly detected cases of cervical cancer within the screening program increased from 0.83% to 2.61%, which indicates that the introduction of the screening program contributes to an increase in the detection of precancerous conditions of the cervix.
Conclusions. The screening program for breast cancer and cervical cancer has shown its effectiveness in detecting new cases of malignant neoplasms of these localizations. An important result of the screening conducted in the Gomel region is the fact that the observed trend towards a decrease in the detection of breast cancer and cervical cancer in the early stages does not give any cause for optimism, as this is evidence of a deterioration in the structure of the detected pathology.
About the Authors
V. S. Volchek
Gomel State Medical University
Belarus
Belarus
Vladislav S. Volchek, Postgraduate student of the Department of Public Health and Healthcare with the course of FPDR
Gomel
T. M. Sharshakova
Gomel State Medical University
Belarus
Belarus
Tamara M. Sharshakova, Doctor of Medical Sciences, Professor, Head of the Department of Public Health and Healthcare with the course of FPDR
Gomel
V. N. Belyakovsky
Gomel State Medical University
Belarus
Belarus
Vasily N. Belyakovsky, Doctor of Medical Sciences, Professor, Professor of the Department of Oncology
Gomel
D. M. Los’
Gomel Regional Clinical Oncologic Dispensary
Belarus
Belarus
Dmitry M. Los’, Chief Physician of Gomel Regional Clinical Oncological Dispensary
Gomel
L. P. Zaitsava
Gomel Regional Clinical Oncologic Dispensary
Belarus
Belarus
Larysa P. Zaitsava, Clinical Laboratory Diagnostician, Head of the Centralized Cytological Laboratory
Gomel
References
1. Habbema D, de Kok I, Brown ML. Cervical cancer screening in the United States and the Netherlands: A tale of two countries. Milbank Quarterly. 2012;90(1):5-37. DOI: https://doi.org/10.1111/j.1468-0009.2011.00652.x
2. Garg V, Gu NY, Borrego ME, Raisch DW. A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening. Expert Rev Pharmacoecon Outcomes Res. 2013;13(3):327-342.
3. Shin S, Kim YH, Hwang JS, Lee YJ, Lee SM, Ahn J. Economic evaluation of prostate cancer screening test as a national cancer screening program in South Korea. Asian Pac J Cancer Prev. 2014;15(8):3383-3389.
4. Pisano ED, Gatsonis G, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breastcancer screening. New Engl J Med. 2005;353:1773-1783. DOI: https://doi.org/10.1056/NEJMoa052911
5. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. J Amer Med Assoc. 2011;305(22):2295-2302. DOI: https://doi.org/10.1001/jama.2011.766
6. On Approval of the Clinical Protocol “Algorithms of Diagnosis and Treatment of Malignant Neoplasms”. [Electronic resource]. Decree of the Ministry of Health of the Russian Federation. Health. Republic of Belarus, July 6. 2018, No. 60. [date of access 2023 January 1]. Available from: https://pravo.by/document/?guid=3961&p0=W21833500p
7. On oncogenetic counseling [Electronic resource]: Order of the Ministry of Health. Zdrav. Republic of Belarus, Dec. 27. 2007, № 1018. [date of access 2023 January 30]. Available from: https://belzakon.net/%D0%97%D0%B0%D0%BA%D0%BE%D0%BD%D0%BE%D0%B4%D0%B0%D1%82%D0%B5%D0%BB%D1%8C%D1%81%D1%82%D0%B2%D0%BE/%D0%9F%D1%80%D0%B8%D0%BA%D0%B0%D0%B7%D1%8B/2007/102706
8. Ronco G., Franceschi S. Cervical cancer screening: the transformational role of routine human papillomavirus testing. Ann. Intern. Med. 2018; 168:75-76. DOI: https://doi.org/10.7326/M17-2872
9. Meijer C.J.L.M., Berkhof J., Castle P.E., et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older. Int J Cancer. 2009; 124 (3): 516-520. DOI: https://doi.org/10.1002/ijc.24010
10. On changing the orders of the Ministry of Health of the Republic of Belarus dated July 28, 2017 No. 830 and February 27, 2018 No. 177 [Electronic resource]: Order of Min. healthy Republic of Belarus, 30 Nov. 2021, No. 1505 [date of access 2023 January 30]. Available from: https://www.bsmu.by/downloads/universitet/lech/2021-2/12-21/10-12/prikaz-1505.pdf
Review
For citations:
Volchek V.S., Sharshakova T.M., Belyakovsky V.N., Los’ D.M., Zaitsava L.P. Evaluation of the implementation of screening programs for early detection of breast and cervical cancer in the Gomel region. Health and Ecology Issues. 2023;20(2):88-97. (In Russ.) https://doi.org/10.51523/2708-6011.2023-20-2-12
Views: 379
Email this article 